Summary

Doctor explains the new treatment and how it differs from a traditional vaccine


Suggested Script

Download full-script: here

Downloadable Content

Download VO: here
Download SOT: here

Expert

Dominic Lucia, MD, at Baylor Scott & White McLane Children's

For Interview or More Information

Email Christina.Millweard@bswhealth.org

Published on 9/12/23

Script

RSV PREVENTATIVE ANTIBODIES
Dominic Lucia, MD, Baylor Scott & White McLane Children's Medical Center

{**ON CAM**}
AS SEASONAL ILLNESSES RAMP UP THIS FALL - THERE WILL BE EXTRA PROTECTION FOR BABIES AGAINST ONE PARTICULARLY PROBLEMATIC ILLNESS CALLED R-S-V.

{**TAKE VO**}
MANY PARENTS BECAME ALL TOO FAMILIAR WITH R-S-V LAST SEASON … AS RATES SURGED IN INFANTS AND CHILDREN.
R-S-V IS A RESPIRATORY ILLNESS THAT CAN LEAD TO HOSPITALIZATION FOR VULNERABLE PEOPLE LIKE YOUNG BABIES.
NOW THE FOOD AND DRUG ADMINISTRATION HAS APPROVED A NEW PREVENTATIVE TREATMENT FOR CHILDREN UNDER THE AGE OF TWO. EMERGENCY MEDICINE PEDIATRICIAN DOCTOR DOMINIC LUCIA (LOO-CHIA) SAYS IT'S A BREAKTHROUGH TREATMENT HEADING INTO WHAT IS EXPECTED TO BE A CHALLENGING SEASON OF VIRUSES... BUT IT'S OFTEN MISLEADINGLY REFERRED TO AS A 'VACCINE'.

{**TAKE SOT**}
Dominic Lucia, MD
Baylor Scott & White McLane Children's Medical Center
TRT: 20
"What we have for infants and toddlers is a monoclonal antibody. So, this is a monoclonal antibody that they can get a shot with and provide short-term protection with their first RSV season for these infants.

{**ON CAM**}
THE PREVENTATIVE ANTIBODY TREATMENT IS APPROVED FOR BABIES GOING INTO THEIR FIRST R-S-V SEASON … AND CHILDREN UNDER THE AGE OF TWO WHO ARE AT HIGHER RISK OF COMPLICATIONS.